ODI Pharma AB

ODI Pharma is a producer and supplier of medical cannabis products. The business is run through subsidiaries and partners where sales go through wholesale distributors and pharmacies. The products are used for the treatment of multiple sclerosis, chronic pain, and chemotherapy. ODI Pharma operates in the European market and is headquartered in Stockholm.

Quotes for ODI Pharma AB

Created with Highstock 6.0.7CloseTraded Volume24. feb7. apr21. apr3. feb10. feb17. feb3. mar17. mar24. mar31. mar14. apr28. apr22.42.83.23.6010T20T30T40T

Right Now

+/-
%
0,00%
Latest
High
Low
Volume
0
Turnover (SEK)
0
Market Value (MSEK)
41,1
Time (Latest trade)

Board

CEO

  • Jan-Mark Edewaard

Chairperson of the Board

  • Volker Wiederrich

Board

  • Gösta Lidén
  • Jan-Mark Edewaard
  • Karina Kilinski
  • Malcolm Allan
  • Articles of association

    • News

    Show More

    News agencies

    Show More

    Analysis

    Videos

    ODI Pharma AB - Company presentation

    ODI Pharma AB - Company presentation

    ODI Pharma AB - Company presentation

    ODI Pharma AB - Company presentation

    ODI Pharma AB - Company presentation

    Largest Owners

    Name Capital % Votes % Date
    Volker Wiederrich 38,95 38,95 2025-03-27
    Niclas Kappelin 28,03 28,03 2025-03-27
    Derek Simmross 24,82 24,82 2025-03-27
    Tomi Kalevi Heikkinen 0,31 0,31 2025-03-27
    Avanza Pension 0,22 0,22 2025-03-27
    Carl Fredrik Christoffer Clementson 0,21 0,21 2025-03-27
    Nordnet Pensionsförsäkring 0,17 0,17 2025-03-27
    Nordnet Livsforsikring AS 0,15 0,15 2025-03-27
    Per Herseth 0,15 0,15 2025-03-27
    Mats Ola Jönsson 0,10 0,10 2025-03-27
    ** Holdings by Modular Finance AB. Compiled and processed data from various sources, including Euroclear, Morningstar and the Swedish Financial Supervisory Authority.

    Insider trading

    NameTransaction DateTypeInstrumentAmountPriceValueCurrency
    Volker Wiederrich2024-12-03en-USODI Pharma 142 8573,22459 999,5SEK
    Volker Wiederrich2023-12-06en-USODI Pharma- 200 0003,5−700 000,0SEK
    Derek Simmross2023-12-06en-USODI Pharma- 2 300 0003,5−8 050 000,0SEK
    Derek Simmross2020-01-23Sell TransactionODI Pharma- 128 53212,01−1 543 222,3SEK
    Volker Wiederrich2020-01-23Sell TransactionODI Pharma- 122 63412,01−1 473 030,6SEK
    Derek Simmross2020-01-16Buy TransactionODI Pharma 128 5329,21 182 494,4SEK
    Volker Wiederrich2020-01-16Buy TransactionODI Pharma 128 5329,21 182 494,4SEK
    *Source: Holdings by Modular Finance AB. Compiled and processed data from the Swedish Financial Supervisory Authority

    Key Numbers

    2024-12-312024-09-302024-06-302024-06-302024-03-312023-12-312023-08-31
    Number of months that the report spans Q2 3 MonthsQ1 3 Months2024Q4 3 MonthsQ3 3 MonthsQ2 3 MonthsQ1 3 Months
    Total revenue MSEK0.000.1422.457.5413.860.000.53
    Earnings before interest and tax MSEK-2.32-1.34-24.21-0.961.581.06-1.23
    Profit before tax MSEK-2.56-1.470.54-1.111.390.95-1.44
    Net profit MSEK-2.56-1.470.36-1.211.300.95-1.44
    Earnings per share SEK-0.00-0.000.000.000.000.00-0.00
    Dividend per share SEK0.00
    Equity MSEK0.450.532.222.223.492.041.05
    Fixed assets MSEK0.010.010.010.010.010.010.01
    Intangible assets MSEK0.000.000.000.000.000.000.00
    Current assets MSEK6.626.0712.2712.2715.457.346.79
    Total asset MSEK6.636.0812.2712.2715.467.356.80
    Long term liabilities MSEK0.000.000.000.000.000.000.00
    Current liabilities MSEK6.185.5510.0610.0611.975.315.75
    Number of shares SEK15.9215.2215.2215.2215.2215.2215.22
    *Compiled data from Millistream

    Upcoming reports

    • 2025-05-29 Delårsrapport 2025-Q3

    Annual reports, prospectus etc.